Published in Br J Surg on March 01, 2003
MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer (2006) 1.68
Endorectal ultrasonography, strain elastography and MRI differentiation of rectal adenomas and adenocarcinomas. Colorectal Dis (2015) 1.43
Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging? Br J Cancer (2004) 1.17
MRI in T staging of rectal cancer: How effective is it? Indian J Radiol Imaging (2010) 1.16
Local staging of rectal cancer: the current role of MRI. Eur Radiol (2006) 1.09
Variations in pelvic dimensions do not predict the risk of circumferential resection margin (CRM) involvement in rectal cancer. World J Surg (2007) 1.07
Current trends in staging rectal cancer. World J Gastroenterol (2011) 1.02
Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging. Br J Radiol (2011) 1.00
Current approaches and challenges for monitoring treatment response in colon and rectal cancer. J Cancer (2014) 1.00
Effect of multidisciplinary team treatment on outcomes of patients with gastrointestinal malignancy. World J Gastroenterol (2011) 0.99
Colorectal cancer: current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation. World J Gastroenterol (2013) 0.97
MRI staging of low rectal cancer. Eur Radiol (2008) 0.94
Factors related to preoperative assessment of the circumferential resection margin and the extent of mesorectal invasion by magnetic resonance imaging in rectal cancer: a prospective comparison study. World J Surg (2009) 0.93
Preoperative staging of rectal cancer: accuracy of 3-Tesla magnetic resonance imaging. Eur Radiol (2006) 0.93
Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer. Br J Cancer (2007) 0.91
Transanal endoscopic microsurgery: a review. Can J Surg (2014) 0.91
The accuracy of Multi-detector row CT for the assessment of tumor invasion of the mesorectal fascia in primary rectal cancer. Abdom Imaging (2008) 0.91
Rectal imaging: part 1, High-resolution MRI of carcinoma of the rectum at 3 T. AJR Am J Roentgenol (2012) 0.89
The mesorectum: morphometric assessment with magnetic resonance imaging. Eur Radiol (2005) 0.89
Computed tomography and magnetic resonance imaging evaluation of lymph node metastasis in early colorectal cancer. World J Gastroenterol (2015) 0.89
MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer. Eur Radiol (2014) 0.88
Robotic versus laparoscopic surgery for mid-low rectal cancer after neoadjuvant chemoradiation therapy: comparison of oncologic outcomes. Int J Colorectal Dis (2013) 0.88
T-staging of rectal cancer: accuracy of 3.0 Tesla MRI compared with 1.5 Tesla. Abdom Imaging (2012) 0.87
Preoperative staging of patients with rectal tumors suitable for transanal endoscopic microsurgery (TEM): comparison of endorectal ultrasound and histopathologic findings. Surg Endosc (2009) 0.87
Proforma-based reporting in rectal cancer. Cancer Imaging (2010) 0.87
Clinical significance of magnetic resonance imaging findings in rectal cancer. World J Radiol (2011) 0.86
Assessment of T staging and mesorectal fascia status using high-resolution MRI in rectal cancer with rectal distention. World J Gastroenterol (2007) 0.86
Laparoscopic extraperitoneal rectal cancer surgery: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc (2011) 0.86
Is there a benefit in using magnetic resonance imaging in the prediction of preoperative neoadjuvant therapy response in locally advanced rectal cancer? Int J Colorectal Dis (2013) 0.85
Efficacy of high resolution magnetic resonance imaging in preoperative local staging of rectal cancer. Mol Imaging Radionucl Ther (2013) 0.84
The Relationship Between MR Demonstration of Extramural Venous Invasion and Nodal Disease in Rectal Cancer. Clin Med Oncol (2008) 0.84
Rectal cancer staging. Clin Colon Rectal Surg (2007) 0.83
MRI after preoperative radiotherapy for rectal cancer; correlation with histopathology and the role of volumetry. Eur Radiol (2007) 0.83
Multidisciplinary discussion and management of rectal cancer: a population-based study. World J Surg (2011) 0.83
Assessment of the prognostic factors for a local recurrence of rectal cancer: the utility of preoperative MR imaging. Korean J Radiol (2005) 0.83
Prediction of tumor stage and lymph node involvement with dynamic contrast-enhanced MRI after chemoradiotherapy for locally advanced rectal cancer. Int J Colorectal Dis (2012) 0.83
Long-term results of local excision for T1 rectal carcinoma: the experience of two colorectal units. Tech Coloproctol (2009) 0.83
Rectal cancer staging: focus on the prognostic significance of the findings described by high-resolution magnetic resonance imaging. Cancer Imaging (2013) 0.82
Circumferential resection margin involvement in stage III rectal cancer patients treated with curative resection followed by chemoradiotherapy: a surrogate marker for local recurrence? Yonsei Med J (2013) 0.81
The value of true axial imaging for CT staging of colonic cancer. Eur Radiol (2010) 0.81
Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases. Radiat Oncol (2011) 0.81
Evaluation of a rabbit rectal VX2 carcinoma model using computed tomography and magnetic resonance imaging. World J Gastroenterol (2009) 0.81
Preoperative diagnosis and staging of rectal cancer using diffusion-weighted and water imaging combined with dynamic contrast-enhanced scanning. Oncol Lett (2014) 0.80
Watch and wait approach to rectal cancer: A review. World J Gastrointest Surg (2015) 0.80
Imaging paradigms in assessment of rectal carcinoma: loco-regional and distant staging. Cancer Imaging (2012) 0.80
Magnetic resonance imaging (MRI)-based indication for neoadjuvant treatment of rectal carcinoma and the surrogate endpoint CRM status. Int J Colorectal Dis (2008) 0.80
Optimal Imaging Strategies for Rectal Cancer Staging and Ongoing Management. Curr Treat Options Oncol (2016) 0.80
Significance of mesorectal volume in staging of rectal cancer with magnetic resonance imaging and the assessment of involvement of the mesorectal fascia. Eur Radiol (2006) 0.79
Selection criteria for the radical treatment of locally advanced rectal cancer. Int J Surg Oncol (2011) 0.79
Staging rectal cancer: endoscopic ultrasound and pelvic MRI. Cancer Imaging (2008) 0.78
Benefit of the measurement of mesorectal extension in patients with pT3N1-2 rectal cancer without pre-operative chemoradiotherapy: Post-operative treatment strategy. Exp Ther Med (2012) 0.78
Regional lymph node metastasis and locoregional recurrence of rectal carcinoma in the era of TME [corrected] surgery. Implications for treatment decisions. Int J Colorectal Dis (2009) 0.78
Magnetic resonance imaging and endorectal ultrasound for diagnosis of rectal lesions. Eur J Med Res (2015) 0.78
Rectal cancer: An evidence-based update for primary care providers. World J Gastroenterol (2015) 0.77
Factors affecting management decisions in rectal cancer in clinical practice: results from a national survey. Tech Coloproctol (2010) 0.77
Accuracy of high-resolution MRI with lumen distention in rectal cancer staging and circumferential margin involvement prediction. Korean J Radiol (2014) 0.77
Prediction of Lateral Pelvic Lymph-Node Metastasis in Low Rectal Cancer by Magnetic Resonance Imaging. World J Surg (2016) 0.77
The impact of lymph node size to predict nodal metastasis in patients with rectal cancer after preoperative chemoradiotherapy. Int J Colorectal Dis (2015) 0.76
Optimised surgery (so-called TME surgery) and high-resolution MRI in the planning of treatment of rectal carcinoma. Langenbecks Arch Surg (2007) 0.76
Comparison of treatment results between surgery alone, preoperative short-course radiotherapy, or long-course concurrent chemoradiotherapy in locally advanced rectal cancer. Int J Clin Oncol (2011) 0.76
The modern anatomical surgical approach to localised rectal cancer. EJC Suppl (2013) 0.76
Laparoscopic total mesorectal excision following long course chemoradiotherapy for locally advanced rectal cancer. Surg Endosc (2011) 0.76
Colorectal Cancer Association of Canada consensus meeting: raising the standards of care for early-stage rectal cancer. Curr Oncol (2009) 0.76
Characteristics and Prognostic Significance of Preoperative Magnetic Resonance Imaging-Assessed Circumferential Margin in Rectal Cancer. Gastroenterol Res Pract (2015) 0.75
Defining the distal margin of rectal cancer for surgical planning. J Gastrointest Oncol (2017) 0.75
Progress in rectal cancer treatment. ISRN Gastroenterol (2012) 0.75
Local massive venous invasion in colorectal cancer: CT-pathological correlation and its clinical implication. Br J Radiol (2015) 0.75
Gastrointestinal imaging-practical magnetic resonance imaging approach. World J Radiol (2014) 0.75
MRI of uncommon lesions of the large bowel: a pictorial essay. J Clin Imaging Sci (2014) 0.75
Combination of three-gene immunohistochemical panel and magnetic resonance imaging-detected extramural vascular invasion to assess prognosis in non-advanced rectal cancer patients. World J Gastroenterol (2016) 0.75
MRI in local staging of rectal cancer: an update. Diagn Interv Radiol (2014) 0.75
The value of high-resolution MRI technique in patients with rectal carcinoma: pre-operative assessment of mesorectal fascia involvement, circumferential resection margin and local staging. Pol J Radiol (2015) 0.75
Nodal staging in rectal cancer: why is restaging after chemoradiation more accurate than primary nodal staging? Int J Colorectal Dis (2016) 0.75
Clinical application of multimodality imaging in radiotherapy treatment planning for rectal cancer. Cancer Imaging (2013) 0.75
Optimizing adjuvant treatment decisions for stage t2 rectal cancer based on mesorectal node size: a decision analysis. Acad Radiol (2012) 0.75
Short-course versus standard chemoradiation in T3 rectal cancer. Oncologist (2011) 0.75
Prognostic significance of a preoperative magnetic resonance imaging assessment of the distance of mesorectal extension in clinical T3 lower rectal cancer. Surg Today (2016) 0.75
MRI T2 hypointensity of metastatic brain tumors from gastric and colonic cancers. Int J Clin Oncol (2013) 0.75
Risk factors for circumferential R1 resection after neoadjuvant radiochemotherapy and laparoscopic total mesorectal excision: a study in 233 consecutive patients with mid or low rectal cancer. Int J Colorectal Dis (2014) 0.75
Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature (1989) 6.70
Mechanism of antigen-driven selection in germinal centres. Nature (1990) 5.26
Transcription cell type specificity is conferred by an immunoglobulin VH gene promoter that includes a functional consensus sequence. Cell (1985) 4.38
Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med (1987) 3.82
GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene (2008) 3.79
Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet (2000) 3.68
Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature (1991) 3.61
Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia. BMJ (1989) 3.34
Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol (1997) 2.98
Transdermal nicotine for active ulcerative colitis. N Engl J Med (1994) 2.90
Double-blind trials. Br J Psychiatry (1990) 2.88
Hyperresponsive B cells in CD22-deficient mice. Science (1996) 2.86
Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen's disease). Histopathology (1991) 2.75
A hapten-specific chimaeric IgE antibody with human physiological effector function. Nature (1985) 2.63
Breakfast and dietary aspects of Crohn's disease. Br Med J (1978) 2.57
Training in large bowel cancer surgery: observations from three prospective regional United Kingdom audits. BMJ (1999) 2.44
Randomized clinical trial of laparoscopic Nissen fundoplication compared with proton-pump inhibitors for treatment of chronic gastro-oesophageal reflux. Br J Surg (2005) 2.42
Colorectal cancer pathology reporting: a regional audit. J Clin Pathol (1997) 2.41
Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit. Br J Surg (1997) 2.36
Four country healthcare associated infection prevalence survey 2006: overview of the results. J Hosp Infect (2008) 2.35
Huntington's Chorea in South Wales. A genetic and epidemiological study. Clin Genet (1981) 2.31
Apoptosis: molecular regulation of cell death. Eur J Biochem (1996) 2.29
Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut (1994) 2.28
Demonstration of somatic mutation and colonic crypt clonality by X-linked enzyme histochemistry. Nature (1988) 2.28
Relation of haemoglobin levels in first and second trimesters to outcome of pregnancy. Lancet (1986) 2.24
Controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis. J Neurol Neurosurg Psychiatry (2001) 2.23
Two transcriptional activators, CCAAT-box-binding transcription factor and heat shock transcription factor, interact with a human hsp70 gene promoter. Mol Cell Biol (1987) 2.17
Granulomatous inflammation--a review. J Clin Pathol (1983) 2.15
Bicycle injuries in children. Br Med J (1977) 2.07
Squamous carcinoma of the colorectum and its genesis. J Pathol (1979) 2.07
Smoking habits in psoriasis: a case control study. Br J Dermatol (1992) 2.03
A life table for onset of Huntington's chorea. Ann Hum Genet (1981) 2.02
Manipulation of the cervical spine--a pilot study. J R Coll Gen Pract (1983) 1.97
The B-cell antigen receptor of the five immunoglobulin classes. Nature (1991) 1.97
Objective birth data and the prediction of child abuse. Arch Dis Child (1981) 1.91
The implementation of guidelines and computerised forms improves the completeness of cancer pathology reporting. The CROPS project: a randomised controlled trial in pathology. Eur J Cancer (2002) 1.88
Familial prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease. Br Med J (1980) 1.88
Huntington's chorea. The basis for long-term prevention. Lancet (1979) 1.87
Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ (1992) 1.86
Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med (1999) 1.83
Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology (1999) 1.82
Factors influencing age at onset and duration of survival in Huntington's chorea. Ann Hum Genet (1981) 1.79
Recombinant antibodies possessing novel effector functions. Nature (1985) 1.76
Antenatal screening by measurement of symphysis-fundus height. Br Med J (Clin Res Ed) (1982) 1.75
Evaluation of axillary lymph nodes using touch imprint cytology and immunohistochemistry. Br J Surg (2002) 1.72
Does health education prevent childhood accidents? Postgrad Med J (1984) 1.69
A clinical and genetic study of Hunter's syndrome. 2. Differences between the mild and severe forms. J Med Genet (1982) 1.66
The Denver Developmental Screening Test. Achievement of test items in the first year of life by Denver and Cardiff infants. Dev Med Child Neurol (1974) 1.66
A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locus. Nature (1990) 1.65
Decline in the predicted incidence of Huntington's chorea associated with systematic genetic counselling and family support. Lancet (1981) 1.64
Patterns of gastritis in patients with gastro-oesophageal reflux disease. Gut (1999) 1.63
Racial variation in the O-acetylation phenotype of human colonic mucosa. J Pathol (1994) 1.62
Mortality in Crohn's disease. Q J Med (1980) 1.62
The intron requirement for immunoglobulin gene expression is dependent upon the promoter. Nucleic Acids Res (1988) 1.60
Detection of three protein binding sites in the serum-regulated promoter of the human gene encoding the 70-kDa heat shock protein. Proc Natl Acad Sci U S A (1987) 1.60
Medication errors in paediatric practice: insights from a continuous quality improvement approach. Eur J Pediatr (1998) 1.59
Unexplained extra visits to general practitioners before the diagnosis of first urinary tract infection: a case-control study. Arch Dis Child (2002) 1.58
Antigen-induced apoptosis in developing T cells: a mechanism for negative selection of the T cell receptor repertoire. Eur J Immunol (1989) 1.58
A genetic register for Huntington's chorea in South Wales. J Med Genet (1982) 1.56
A stem cell niche theory of intestinal crypt maintenance based on a study of somatic mutation in colonic mucosa. Am J Pathol (1992) 1.56
Nitric oxide mediates a therapeutic effect of nicotine in ulcerative colitis. Aliment Pharmacol Ther (2000) 1.55
Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology. Eur J Cancer (1994) 1.54
Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm. Histopathology (1994) 1.53
Inter- and intra-observer variation in the reporting of cervical smears: specialist cytopathologists versus histopathologists. Cytopathology (1996) 1.52
Oral folate enhances endothelial function in hyperhomocysteinaemic subjects. Eur J Clin Invest (1999) 1.51
Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. Biochim Biophys Acta (2013) 1.50
The mouse IgH 3'-enhancer. Eur J Immunol (1991) 1.50
The British Society of Gastroenterology early gastric cancer/dysplasia survey: an interim report. Gut (1990) 1.49
Role of DNA breaks and ADP-ribosyl transferase activity in eukaryotic differentiation demonstrated in human lymphocytes. Nature (1982) 1.48
Cells strongly expressing Ig(kappa) transgenes show clonal recruitment of hypermutation: a role for both MAR and the enhancers. EMBO J (1997) 1.46
Tables for estimation of individual risks of fetal neural tube and ventral wall defects, incorporating prior probability, maternal serum alpha-fetoprotein levels, and ultrasonographic examination results. Am J Obstet Gynecol (1991) 1.46
The immune competence of patients with inflammatory bowel disease. Gut (1974) 1.43
Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases. Arch Dis Child (1979) 1.43
The chemical stain removal properties of 'whitening' toothpaste products: studies in vitro. Br Dent J (2000) 1.43
Maternal smoking habits and congenital malformations: a population study. Br Med J (1979) 1.43
Primary epithelioid haemangioendothelioma of the peritoneum: an unusual mimic of diffuse malignant mesothelioma. Histopathology (1997) 1.43
Abdominal lymphoma--the place for surgery. J R Soc Med (1989) 1.42
Increased sugar consumption in Crohn's disease. Digestion (1980) 1.42
A clinical evaluation of the Accutracker--a lightweight ambulatory blood pressure monitor. J Hum Hypertens (1989) 1.39
Intra-observer reliability regarding removal of asymptomatic third molars. Br Dent J (1998) 1.39
Hemin-induced transcriptional activation of the HSP70 gene during erythroid maturation in K562 cells is due to a heat shock factor-mediated stress response. Mol Cell Biol (1989) 1.38
Controlled trial of supplemented oral nutrition in Crohn's disease. Lancet (1983) 1.37
Standardisation of the Denver Developmental Screening Test for Cardiff children. Dev Med Child Neurol (1979) 1.37
Limitations of double-blind trials. Br J Psychiatry (1990) 1.35
Metaplastic polyps and polyposis of the colorectum. Histopathology (1980) 1.31
The half-life of immunoglobulin mRNA increases during B-cell differentiation: a possible role for targeting to membrane-bound polysomes. Genes Dev (1988) 1.31
Functional significance of an overlapping consensus binding motif for Sp1 and Zif268 in the murine adenosine deaminase gene promoter. Proc Natl Acad Sci U S A (1991) 1.31
Caspase activity is required for commitment to Fas-mediated apoptosis. EMBO J (1997) 1.30
Adverse reactions to patent blue V dye - The NEW START and ALMANAC experience. Eur J Surg Oncol (2009) 1.30